<!doctype html><html><head><meta charset=utf-8><meta http-equiv=x-ua-compatible content="ie=edge"><meta name=viewport content="width=device-width,initial-scale=1,shrink-to-fit=no"><title>Cell fate decision network in the AGS gastric cancer cell line (Flobak et al 2015) &#183; GINsim</title><meta name=description content><link rel=stylesheet href=https://ginsim.github.io/style.main.css></head><body><header><div class=title><a href=https://ginsim.github.io/><img src=https://ginsim.github.io/ginsim.svg class=logo alt=GINsim></a></div><nav><ul><li><a href=/>Home</a></li><li><a href=/doc/>Documentation</a></li><li><a href=/download/>Download</a></li><li><a href=/models/>Models</a></li></ul></nav></header><section><div class=content><h1>Cell fate decision network in the AGS gastric cancer cell line (Flobak et al 2015)</h1><div class=meta><dl><dt>Submitter</dt><dd>D. Thieffry / C. Chaouiya</dd><dt>Taxon</dt><dd><span class=keyword>Mammal</span></dd><dt>Process</dt><dd><span class=keyword>Cancer</span></dd><p class=ref><span class=title>Discovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical Modeling..</span>
<span class=authors>Å. Flobak, A. Baudot, E. Remy, L. Thommesen, D. Thieffry, M. Kuiper, A. Lægreid.</span>
<span class=journal>PLoS computational biology</span>
<span class=position>11</span><span class=year> (2015 Aug)</span>.<br><span class=links>[
<span class=doi><a href=http://dx.doi.org/10.1371/journal.pcbi.1004426>doi:10.1371/journal.pcbi.1004426</a></span>
<span class=issn><a href=1553-7358>issn</a></span>
]</span></p></div><p>This model accounts for cell fate decision network in the AGS gastric cancer
cell line. A set of logical equations has been defined, wich recapitulates AGS
data observed in cells in their baseline proliferative state. Using the
modeling software GINsim, model reduction and simulation compression
techniques were applied to cope with the vast state space of large logical
models and enable simulations of pairwise applications of specific signaling
inhibitory chemical substances. These simulations predicted synergistic growth
inhibitory action of five combinations from a total of 21 possible pairs. All
predicted non synergic pairs and four of the predicted synergic ones were
confirmed in AGS cell growth real-time assays, including known synergic
effects of MEK-AKT or MEK-PI3K inhibitions, along with novel synergistic
effects of combined TAK1-AKT or TAK1-PI3K inhibitions.</p><h3>Files</h3><ul><li><a href=Flobak_FullModel_S2_Dataset.zginml>Flobak_FullModel_S2_Dataset.zginml</a></li><li><a href=Flobak_ReducedModel_S3_Dataset.zginml>Flobak_ReducedModel_S3_Dataset.zginml</a></li></ul></div></section></body></html>